1,2 diarylbenzimdazoles and their pharmaceutical use
申请人:Schering AG
公开号:US20020006948A1
公开(公告)日:2002-01-17
Benzimidazoles of general formula I
1
and the use of benzimidazole derivatives for the production of pharmaceutical agents for treatment and prophylaxis of diseases that are associated with a microglia activation are described.
Dyeing composition comprising a cationic tertiary para-phenylenediamine and heterocyclic coupler, methods and uses
申请人:L'OREAL
公开号:US20040231067A1
公开(公告)日:2004-11-25
The subject of the present application is a dyeing composition for dyeing keratinous fibres, in particular human keratinous fibres such as hair, comprising, in an appropriate dyeing medium, at least one cationic tertiary para-phenylenediamine containing a pyrrolidine ring, and at least one particular heterocyclic coupler.
The subject of the invention is also the dyeing method using this composition.
1,2 Diarylbenzimidazoles and their pharmaceutical use
申请人:Halfbrodt Wolfgang
公开号:US20060094770A1
公开(公告)日:2006-05-04
Benzimidazoles of general formula I
and the use of benzimidazole derivatives for the production of pharmaceutical agents for treatment and prophylaxis of diseases that are associated with a microglia activation are described.
1,2 diarylbenzimidazoles and their pharmaceutical use
申请人:Schering Aktiengesellschaft
公开号:US07115645B2
公开(公告)日:2006-10-03
Benzimidazoles of general formula I
and the use of benzimidazole derivatives for the production of pharmaceutical agents for treatment and prophylaxis of diseases that are associated with a microglia activation are described.
本文描述了一般式I的苯并咪唑及其衍生物的用途,用于生产治疗和预防与微胶质细胞激活相关疾病的药物。
1,2-DIARYLBENZIMIDAZOLE ZUR BEHANDLUNG VON ERKRANKUNGEN DIE MIT EINER MICROGLIA-AKTIVIERUNG ASSOZIIERT SIND